Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data.
Saved in:
| Title: | Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data. |
|---|---|
| Authors: | Nijs M; Janssen Research and Development, LLC, Department of Global Analytics - Neuroscience, Titusville., Wajs E; Janssen Research and Development, Belgium, Department of Neuroscience, Beerse, Belgium., Aluisio L; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA., Turkoz I; Janssen Research and Development, LLC, Department of Statistics & Decision Sciences, Titusville, NJ., Daly E; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ., Janik A; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA., Borentain S; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ., Singh JB; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA., DiBernardo A; Janssen Research and Development, France, Department of Clinical Medical Affairs, Issy-les-Moulineaux, France., Wiegand F; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ. |
| Source: | The international journal of neuropsychopharmacology [Int J Neuropsychopharmacol] 2020 Jul 29; Vol. 23 (7), pp. 426-433. |
| Publication Type: | Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9815893 Publication Model: Print Cited Medium: Internet ISSN: 1469-5111 (Electronic) Linking ISSN: 14611457 NLM ISO Abbreviation: Int J Neuropsychopharmacol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 32270176 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Nijs+M%22">Nijs M</searchLink>; Janssen Research and Development, LLC, Department of Global Analytics - Neuroscience, Titusville.<br /><searchLink fieldCode="AU" term="%22Wajs+E%22">Wajs E</searchLink>; Janssen Research and Development, Belgium, Department of Neuroscience, Beerse, Belgium.<br /><searchLink fieldCode="AU" term="%22Aluisio+L%22">Aluisio L</searchLink>; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA.<br /><searchLink fieldCode="AU" term="%22Turkoz+I%22">Turkoz I</searchLink>; Janssen Research and Development, LLC, Department of Statistics & Decision Sciences, Titusville, NJ.<br /><searchLink fieldCode="AU" term="%22Daly+E%22">Daly E</searchLink>; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ.<br /><searchLink fieldCode="AU" term="%22Janik+A%22">Janik A</searchLink>; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA.<br /><searchLink fieldCode="AU" term="%22Borentain+S%22">Borentain S</searchLink>; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ.<br /><searchLink fieldCode="AU" term="%22Singh+JB%22">Singh JB</searchLink>; Janssen Research and Development, LLC, Department of Neuroscience, San Diego, CA.<br /><searchLink fieldCode="AU" term="%22DiBernardo+A%22">DiBernardo A</searchLink>; Janssen Research and Development, France, Department of Clinical Medical Affairs, Issy-les-Moulineaux, France.<br /><searchLink fieldCode="AU" term="%22Wiegand+F%22">Wiegand F</searchLink>; Janssen Research and Development, LLC, Department of Clinical Medical Affairs, Titusville, NJ. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229815893%22">The international journal of neuropsychopharmacology</searchLink> [Int J Neuropsychopharmacol] 2020 Jul 29; Vol. 23 (7), pp. 426-433. – Name: TypePub Label: Publication Type Group: TypPub Data: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9815893 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1469-5111 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214611457%22">14611457 </searchLink><i>NLM ISO Abbreviation: </i>Int J Neuropsychopharmacol <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=32270176 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1093/ijnp/pyaa027 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 426 Titles: – TitleFull: Managing Esketamine Treatment Frequency Toward Successful Outcomes: Analysis of Phase 3 Data. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Nijs M – PersonEntity: Name: NameFull: Wajs E – PersonEntity: Name: NameFull: Aluisio L – PersonEntity: Name: NameFull: Turkoz I – PersonEntity: Name: NameFull: Daly E – PersonEntity: Name: NameFull: Janik A – PersonEntity: Name: NameFull: Borentain S – PersonEntity: Name: NameFull: Singh JB – PersonEntity: Name: NameFull: DiBernardo A – PersonEntity: Name: NameFull: Wiegand F IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 07 Text: 2020 Jul 29 Type: published Y: 2020 Identifiers: – Type: issn-electronic Value: 1469-5111 Numbering: – Type: volume Value: 23 – Type: issue Value: 7 Titles: – TitleFull: The international journal of neuropsychopharmacology Type: main |
| ResultId | 1 |
